IntelGenx Technologies announced that its wholly-owned subsidiary, IntelGenx, has received a fourth and final term loan tranche in the amount of U.S.$3 million pursuant to its amended and restated secured loan agreement with atai Life Sciences. The obligations under the Loan are guaranteed by the Company.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on IGXT: